Untreated effects of breast cancer care increase depression and anxiety among survivors

December 9, 2016, Perelman School of Medicine at the University of Pennsylvania

Treatment advances have increased the five-year survival rate for breast cancer to 90 percent. But, for many of the 2.8 million survivors in the United States, the price of survival includes severe physical and psychosocial symptoms—including joint pain, fatigue, weight gain and insomnia—that may go untreated and persist for many years after treatment. Long-term survivors report an average three symptoms for which they desire more help than they are receiving, according to new research from the Perelman School of Medicine and the Abramson Cancer Center of the University of Pennsylvania. Additional results show a significant relationship between untreated symptoms and anxiety and depression among these patients. Researchers are calling on health care providers to think beyond the disease, and incorporate symptom management more frequently into routine follow-up care. Results of the study will be presented on Friday at the 2016 San Antonio Breast Cancer Symposium (poster P5-13-12).

"There's almost an unwritten 'don't ask, don't tell' mentality about residual and persistent side effects of ," said lead author Steven Palmer, PhD, a research scientist at the Abramson Cancer Center. "Clinicians seeing patients for routine follow-up care may be focusing on recurrence prevention and detection to the exclusion of long term symptoms and whether survivors need help managing them. This lack of attention to potential symptoms can lead to increased levels of anxiety and depression for these cancer survivors."

In the study, 103 who have been disease-free for at least three years completed surveys assessing the prevalence and severity of nineteen symptoms and whether they would like help managing those symptoms. Anxiety and depressive symptoms were also reported by participants using the Hospital Anxiety and Depression Scale.

Results show 92 percent of survivors reported at least three long-term symptoms, primarily fatigue, aching joints, , memory trouble, or insomnia, while 65 percent had at least one unmet need for intervention, with the average survivor reporting three unmet needs. Additional results show that breast cancer survivors living with more needs for symptom management are also more likely to experience anxiety and depression. The researchers suggest that when extended to the larger breast cancer survivor population, more than 1,300,00 breast could be experiencing at least three specific symptoms for which they need assistance.

Services to assist with survivorship care are becoming more commonplace, but the authors suggest that for many patients, long term go unaddressed in either cancer or primary care settings, and appropriate treatments and referrals are not being made.

"Survivorship care is about more than screenings and disease prevention. It's about the whole person," said senior author Linda A. Jacobs, PhD, CRNP, director of Cancer Survivorship Programs at Penn's Abramson Cancer Center. "Our results point to a need for a more holistic view of care where providers are thinking about what happens next for these patients and guiding them to services that can help improve their quality of life on multiple levels."

Explore further: Web-based cognitive exercises improve memory and attention in cancer survivors

Related Stories

Web-based cognitive exercises improve memory and attention in cancer survivors

October 31, 2016
A new study suggests that a widely available web-based program (Insight) can help cancer survivors reporting cognitive symptoms. The 15-week program markedly improved participants' self-reported (perceived) cognitive function, ...

Recovering Latina breast cancer patients report big gaps in 'survivorship' care

December 1, 2016
Breast cancer patients in one of the United States' largest and fastest-growing ethnic minority groups are likely to experience numerous gaps in care following their primary treatment, research from Oregon State University ...

New guideline addresses long-term needs of breast cancer survivors

December 7, 2015
A new breast cancer survivorship care guideline created by the American Cancer Society and the American Society of Clinical Oncology provides guidance to primary care and other clinicians in caring for the estimated 3.1 million ...

Cancer survivor guidelines not always followed, researcher finds

November 13, 2015
Researcher Marian Luctkar-Flude (PhD candidate, School of Nursing) has found that a majority of primary care providers surveyed are not routinely following many of the care guidelines for breast cancer survivors. The main ...

Researchers conduct study with innovative tools to help early identification and treatment of lymphedema

September 30, 2016
Each year, about 1.38 million women worldwide are diagnosed with breast cancer. Advances in diagnosis and treatment have facilitated a 90 percent, five-year survival rate, among those treated. Given the increased rate and ...

Some adolescent cancer survivors may require more comprehensive mental health screening

July 18, 2016
Most adolescent survivors of childhood cancer have no reported psychological symptoms, but an analysis led by St. Jude Children's Research Hospital found that those who do often have multiple symptoms and distinct symptom ...

Recommended for you

From the ashes of a failed pain drug, a new therapeutic path emerges

November 16, 2018
In 2013, renowned Boston Children's Hospital pain researcher Clifford Woolf, MB, BCh, Ph.D., and chemist Kai Johnsson, Ph.D., his fellow co-founder at Quartet Medicine, believed they held the key to non-narcotic pain relief. ...

Repurposing FDA-approved drugs can help fight back breast cancer

November 16, 2018
Screening Food and Drug Administration (FDA)-approved compounds for their ability to stop cancer growth in the lab led to the finding that the drug flunarizine can slow down the growth of triple-negative breast cancer in ...

Traditional chemotherapy superior to new alternative for oropharyngeal cancers

November 16, 2018
A drug increasingly used in combination with radiotherapy to treat a type of cancer that forms in the tonsils or the base of the tongue is inferior to a previously favored option, according to a large, clinical trial led ...

New 'SLICE' tool can massively expand immune system's cancer-fighting repertoire

November 15, 2018
Immunotherapy can cure some cancers that until fairly recently were considered fatal. In addition to developing drugs that boost the immune system's cancer-fighting abilities, scientists are becoming expert at manipulating ...

Standard chemotherapy treatment for HPV-positive throat cancer remains the most effective, study finds

November 15, 2018
A new study funded by Cancer Research UK and led by the University of Birmingham has found that the standard chemotherapy used to treat a specific type of throat cancer remains the most effective.

Anti-malaria drugs have shown promise in treating cancer, and now researchers know why

November 15, 2018
Anti-malaria drugs known as chloroquines have been repurposed to treat cancer for decades, but until now no one knew exactly what the chloroquines were targeting when they attack a tumor. Now, researchers from the Abramson ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.